Scholarlink

<p>The impact of endometrioma size on ovarian reserve remains controversial. Although endometriomas are known to reduce anti-Müllerian hormone (AMH) levels, some studies suggest a paradoxical association between larger cysts and higher AMH. This cross-sectional study enrolled 210 infertile women between January 2023 and March 2025: 150 with laparoscopy-confirmed untreated unilateral endometriomas and 60 controls with male-factor infertility and normal ovaries. Serum AMH, follicle-stimulating hormone, luteinizing hormone, and prolactin were measured on cycle day 3. Endometrioma diameter was measured by transvaginal ultrasound. AMH levels were compared across cyst size categories (≤ 30&#xa0;mm, 31–50&#xa0;mm, &gt; 50&#xa0;mm) using one-way analysis of variance and multiple linear regression, adjusting for age and follicle-stimulating hormone. Mean AMH levels did not differ significantly between the endometrioma and control groups (2.24 ± 1.90 vs. 2.38 ± 1.45 ng/mL; <i>p</i> = 0.30). Within the endometrioma cohort, AMH increased with cyst size (F = 4.98, <i>p</i> = 0.008): 1.72 ± 1.26 ng/mL (≤ 30&#xa0;mm), 2.23 ± 1.78 ng/mL (31–50&#xa0;mm), and 2.70 ± 1.69 ng/mL (&gt; 50&#xa0;mm). Post hoc analysis showed significantly higher AMH in cysts &gt; 50&#xa0;mm compared with ≤ 30&#xa0;mm (<i>p</i> = 0.01). In multivariable regression analysis, cyst diameter independently predicted AMH levels (β = 0.031, <i>p</i> &lt; 0.001). Larger endometriomas were paradoxically associated with higher AMH levels. Interpretation of AMH in women with endometriomas should be context-dependent, and clinical decisions regarding ovarian reserve should not rely solely on cyst size or AMH values.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The paradoxical association between endometrioma size and serum anti-Müllerian hormone levels in infertile women

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月4日

查看全文
  • Sogand Khalilnezhad Kordi,
  • Sedighe Esmaeilzadeh,
  • Zahra Basirat,
  • Hoda Shirafkan,
  • Parvaneh Mirabi

摘要

The impact of endometrioma size on ovarian reserve remains controversial. Although endometriomas are known to reduce anti-Müllerian hormone (AMH) levels, some studies suggest a paradoxical association between larger cysts and higher AMH. This cross-sectional study enrolled 210 infertile women between January 2023 and March 2025: 150 with laparoscopy-confirmed untreated unilateral endometriomas and 60 controls with male-factor infertility and normal ovaries. Serum AMH, follicle-stimulating hormone, luteinizing hormone, and prolactin were measured on cycle day 3. Endometrioma diameter was measured by transvaginal ultrasound. AMH levels were compared across cyst size categories (≤ 30 mm, 31–50 mm, > 50 mm) using one-way analysis of variance and multiple linear regression, adjusting for age and follicle-stimulating hormone. Mean AMH levels did not differ significantly between the endometrioma and control groups (2.24 ± 1.90 vs. 2.38 ± 1.45 ng/mL; p = 0.30). Within the endometrioma cohort, AMH increased with cyst size (F = 4.98, p = 0.008): 1.72 ± 1.26 ng/mL (≤ 30 mm), 2.23 ± 1.78 ng/mL (31–50 mm), and 2.70 ± 1.69 ng/mL (> 50 mm). Post hoc analysis showed significantly higher AMH in cysts > 50 mm compared with ≤ 30 mm (p = 0.01). In multivariable regression analysis, cyst diameter independently predicted AMH levels (β = 0.031, p < 0.001). Larger endometriomas were paradoxically associated with higher AMH levels. Interpretation of AMH in women with endometriomas should be context-dependent, and clinical decisions regarding ovarian reserve should not rely solely on cyst size or AMH values.